Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy.

Published in:

Oncogenesis, 2017, v. 6, n. 1, p. e295, doi. 10.1038/oncsis.2016.86

By:

• Xu, B;
• Lefringhouse, J;
• Liu, Z;
• West, D;
• Baldwin, L A;
• Ou, C;
• Chen, L;
• Napier, D;
• Chaiswing, L;
• Brewer, L D;
• St. Clair, D;
• Thibault, O;
• van Nagell, J R;
• Zhou, B P;
• Drapkin, R;
• Huang, J-A;
• Lu, M L;
• Ueland, F R;
• Yang, X H

Publication type:

Article